Valuation: PharmaEssentia Corporation

Market Cap 493B 15.51B 13.44B 12.68B 11.51B 21.58B 1,486B 21.74B 151B 58.36B 754B 58.25B 56.97B 2,397B P/E 2026 *
44.9x
P/E 2027 * 28.2x
Enterprise Value 467B 14.67B 12.72B 12B 10.89B 20.42B 1,407B 20.57B 143B 55.22B 714B 55.12B 53.9B 2,268B EV / Sales 2026 *
16.5x
EV / Sales 2027 * 11.4x
Free-Float
77.98%
Yield 2026 *
0.34%
Yield 2027 * 0.2%
1 day-7.03%
1 week-10.19%
Current month-14.70%
1 month-20.67%
3 months+39.10%
6 months+100.92%
Current year+180.86%
1 week 1,165
Extreme 1165
1,405
1 month 1,165
Extreme 1165
1,645
Current year 423.7
Extreme 423.699083
1,645
1 year 407.92
Extreme 407.923053
1,645
3 years 228.27
Extreme 228.269713
1,645
5 years 56.05
Extreme 56.051993
1,645
10 years 43.54
Extreme 43.541837
1,645
Manager TitleAgeSince
Chief Executive Officer - 2016-12-31
Director of Finance/CFO - 2015-10-13
President - 2015-06-24
Director TitleAgeSince
Director/Board Member - 2000-05-08
Chairman - 2012-09-23
Director/Board Member - 2015-05-28
Change 5-day change 1-year change 3-year change Capi.($)
-7.03%-10.19%+161.91%+303.00% 15.51B
+5.04%+3.66%+50.62%+103.77% 70.24B
-0.92%-0.69%+34.76%+75.36% 62.63B
-3.18%-0.78%-14.14%+369.82% 27.36B
+0.12%-0.16%+26.73%+12.12% 25.71B
+2.20%-4.72%+2.19%-13.14% 24.83B
-1.25%-3.33%+17.65%-21.55% 19.52B
-4.53%-5.66%-9.55%+482.78% 14.66B
+4.96%+4.63%-2.75%+864.40% 14.69B
+0.16%-4.74%+43.58%+152.40% 13.93B
Average -0.42%-2.12%+31.10%+232.90% 28.91B
Weighted average by Cap. +0.51%-0.99%+32.41%+167.06%

Financials

2026 *2027 *
Net sales 28.33B 891M 772M 728M 661M 1.24B 85.39B 1.25B 8.7B 3.35B 43.32B 3.35B 3.27B 138B 40.06B 1.26B 1.09B 1.03B 935M 1.75B 121B 1.77B 12.3B 4.74B 61.25B 4.73B 4.63B 195B
Net income 11.02B 347M 300M 283M 257M 482M 33.22B 486M 3.38B 1.3B 16.85B 1.3B 1.27B 53.58B 17.69B 556M 482M 455M 413M 774M 53.32B 780M 5.43B 2.09B 27.05B 2.09B 2.04B 85.99B
Net Debt -26.52B -834M -723M -682M -619M -1.16B -79.95B -1.17B -8.15B -3.14B -40.56B -3.13B -3.06B -129B -34.73B -1.09B -946M -893M -810M -1.52B -105B -1.53B -10.67B -4.11B -53.1B -4.1B -4.01B -169B
Logo PharmaEssentia Corporation
PHARMAESSENTIA CORPORATION is a Taiwan-based company primarily engaged in the research and development, clinical trials, manufacturing, sale, and marketing of innovative biotechnology drugs. It also oversees registration and marketing authorization applications based on product development progress. The Company focuses on hematology and oncology, utilizing the PEGylation technology platform for drug candidate design and development. The Company’s proprietary product, Ropeg, is used to treat polycythemia vera (PV), primarily sold in the United States.
Employees
131
Date Price Change Volume
26-09-14 NT$1,190.00 -7.03% 5,500,524
26-09-11 NT$1,280.00 -3.03% 2,676,454
26-09-10 NT$1,320.00 -1.86% 2,750,274
26-09-09 NT$1,345.00 -4.27% 4,564,007
26-09-08 NT$1,405.00 +6.04% 4,860,872
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1,190.00TWD
Average target price
1,397.26TWD
Spread / Average Target
+17.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!